Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial (Q33349888)

26 July 2017

title

Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial (English)

1 reference

26 July 2017

main subject

phase II clinical trial

0 references

1 reference

C-H Köhne

1

1 reference

26 July 2017

R Catane

2

1 reference

26 July 2017

B Klein

3

1 reference

26 July 2017

M Ducreux

4

1 reference

26 July 2017

P Thuss-Patience

5

1 reference

26 July 2017

N Niederle

6

1 reference

26 July 2017

M Gips

7

1 reference

26 July 2017

P Preusser

8

1 reference

26 July 2017

A Knuth

9

1 reference

26 July 2017

M Clemens

10

1 reference

26 July 2017

R Bugat

11

1 reference

26 July 2017

I Figer

12

1 reference

26 July 2017

A Shani

13

1 reference

26 July 2017

B Fages

14

1 reference

26 July 2017

D Di Betta

15

1 reference

26 July 2017

C Jacques

16

1 reference

26 July 2017

H J Wilke

17

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

British Journal of Cancer

26 July 2017

published in

1 reference

26 July 2017

volume

89

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

997-1001

1 reference

Developments in the treatment of gastric cancer in Europe

26 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376958

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376958

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376958

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376958

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376958

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376958

A review of chemotherapy in gastric cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376958

Current status of chemotherapy for advanced pancreatic and gastric cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376958

Current status of chemotherapy for gastric cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376958

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.

28 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601226

Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601226

Uracil-tegafur in gastric carcinoma: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601226

Cancer of the stomach. A patient care study by the American College of Surgeons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601226

Rising incidence of adenocarcinoma of the esophagus and gastric cardia

21 January 2018

1 reference

12 December 2020

One-sample multiple testing procedure for phase II clinical trials

1 reference

12 December 2020

[Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group]

1 reference

12 December 2020

5-fluorouracil vs. epirubicin vs. 5-fluorouracil plus epirubicin in advanced gastric carcinoma

1 reference

12 December 2020

Phase II study of Taxol in patients with advanced gastric carcinoma

1 reference

12 December 2020

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

1 reference

12 December 2020

Extended lymph-node dissection for gastric cancer

1 reference

12 December 2020

Progress in gastric cancer surgery in Japan and its limits of radicality

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6601226

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference